Literature DB >> 13817333

Bretylium tosylate in the treatment of hypertension.

C T DOLLERY, D EMSLIE-SMITH, J McMICHAEL.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; SYMPATHOLYTICS/therapy

Mesh:

Substances:

Year:  1960        PMID: 13817333     DOI: 10.1016/s0140-6736(60)90233-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Guanethidine in the treatment of severe hypertension.

Authors:  H T SEARS
Journal:  J Coll Gen Pract       Date:  1962-05

2.  Bretylium tosylate in treatment of severe hypertension.

Authors:  K SOMERS
Journal:  Br Med J       Date:  1962-03-31

3.  Guanethidine as the sole agent in the treatment of hypertension.

Authors:  G R CUMMING; B SWAIN
Journal:  Can Med Assoc J       Date:  1961-01-28       Impact factor: 8.262

4.  Treatment of severe hypertension with bretylium tosylate.

Authors:  E F MONTUSCHI; H E PEARSON; L L WILSON
Journal:  Br Med J       Date:  1960-10-22

5.  Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate.

Authors:  C P LOWTHER; R W TURNER
Journal:  Br Med J       Date:  1960-10-08

6.  Studies on a new hypotensive agent: bretylium tosylate.

Authors:  J GENEST; G DUFAULT; G PIGEON; J DAVIGNON; P BIRON; J TRUDEL
Journal:  Can Med Assoc J       Date:  1960-04-23       Impact factor: 8.262

7.  The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves.

Authors:  A L BOURA; F C COPP; W G DUNCOMBE; A F GREEN; A McCOUBREY
Journal:  Br J Pharmacol Chemother       Date:  1960-06

8.  The papers of John McMichael.

Authors: 
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

9.  Pharmacokinetics of bretylium in man after intravenous administration.

Authors:  P K Narang; J Adir; J Josselson; A Yacobi; J Sadler
Journal:  J Pharmacokinet Biopharm       Date:  1980-08

Review 10.  Clinical pharmacokinetics of bretylium.

Authors:  W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.